Debra Valsamis
Recent posts by Debra Valsamis
2 min read
Antibody Solutions Licenses Novel Fc Silencing Technology from mAbsolve
(Santa Clara, CA) December 4, 2023 -- Antibody Solutions, a leading provider of custom antibody services to the bio-pharamceutical market, and mAbsolve, developers of a novel Fc silencing variant, today announced a licensing deal for mAbsolve’s Fc silencing technology. The agreement provides Antibody Solutions with access to the new STR Fc silencing platform. The agreement provides Antibody Solutions clients with easy license-free access to the new STR Fc silencing platform for antibody research and development.
3 min read
Climbing Mountains and Fighting Cancer – Fred Hutch Style
Editor’s Note: This is the second in a two-part blog series that takes us along with Rondo Therapeutics co-founder and President Nathan Trinklein as he ascends Mt. Kilimanjaro to raise funds for cancer research.
3 min read
A Literal “Peak Experience” for Cancer Research
Editor’s Note: This is the first in a multi-part blog series that takes us along with Rondo Therapeutics co-founder and President Nathan Trinklein as he ascends Mt. Kilminjaro to raise funds for cancer research.
2 min read
John Kenney presents Cellestive discovery platform at 2022 AET Conference
Once again, Antibody Solutions was proud to participate as an event sponsor in the annual Antibody Engineering and Therapeutics (AET) conference, hosted at the Marriott Marquis San Diego Marina. Antibody Solutions’ Co-Founder and President, John Kenney, PhD, delivered a presentation: Capturing the Functional Antibody Repertoire from Multiple B-cell Subsets Following Antigen Stimulation.
Topics: Events
3 min read
Global Spotlight Shines on mRNA Thanks to Pfizer, BioNTech COVID-19 Vaccine Candidate
In the science shot heard ‘round the world, Pfizer and BioNTech announced Monday that their vaccine candidate (aka “BNT162b2”) appears to be more than 90% effective in preventing SARS-CoV-2 among those without evidence of prior infection. And since that news broke on the same day that the number of confirmed U.S. cases of COVID-19 crossed yet another grim threshold — 10 million infected — it couldn’t have come at a better time.
Topics: Insights SARS-CoV-2 COVID-19 mRNA
6 min read
"The secret of life is enjoying the passage of time": Dr. John Kenney's Grand Opening Remarks
On January 30, 2020, Antibody Solutions held a celebration to commemorate both of our new expanded facility in Santa Clara, Calif., and our 25th anniversary, As part of the event, the company's president and co-founder, Dr. John Kenney, delivered a compelling and inspiring keynote address to our valued guests. In addition to recognizing and thanking all of our employees, clients and friends through the years, John offered his perspectives on the growth and progress of Antibody Solutions since our founding in 1995 and shared some "lessons learned" from his career that he believes will guide our success for next 25 years. His remarks are included below.
Topics: Insights 25th Anniversary
2 min read
Antibody Solutions Announces Partnership with SCT at 2017 Antibody Engineering & Therapeutics Conference
Antibody Solutions, a leader in discovery of therapeutic, biomarker and critical reagent antibodies, and Single Cell Technology, Inc. (SCT), a pioneer in single cell analysis technology, have launched a partnership that offers pharmaceutical researchers one-stop access to advanced single B-cell antibody discovery capabilities.